Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aileron Therapeutics Q2 EPS $(0.09) Down From $(0.06) YoY

Author: Bill Haddad | August 15, 2022 05:07pm
Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.09) per share. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year.

Posted In: ALRN


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist